Ronald J. Ellis, Jr., DO
Ron Ellis brings over 20 years of healthcare experience in medicine, clinical research, equity research and institutional investing. Dr. Ellis is currently Senior Vice President of Corporate Strategy & Business Development at Pacira BioSciences, Inc., where he leads the company’s efforts in strategy, licensing and acquisition.
Dr. Ellis was a Managing Director at Leerink Partners, a boutique healthcare investment bank, advising institutional investors on healthcare trends, strategy, and capital markets across a broad array of investment instruments, including equities, derivatives and convertibles.
Dr. Ellis was a Healthcare Trading Specialist at Citigroup Global Markets and Deutsche Bank Securities. He was a Biotechnology Analyst in Equity Research at Prudential Securities and Leerink Swann. He began his Wall Street career as an Associate on the specialty pharmaceuticals equity research team at ING Barings, which was subsequently acquired by ABN Amro.
Dr. Ellis did his Post-Doctoral work in Pharmacoeconomics and Health Outcomes, as a Wyeth-Ayerst Fellow (later acquired by Pfizer). He earned his medical degree and Internal Medicine Internship from the Philadelphia College of Osteopathic Medicine and his M.B.A. with a concentration in Medical Management from St. Joseph’s University, where he also pursued post-M.B.A. studies in Pharmaceutical Marketing.